- Home
- CPBI vs VNRX Comparison
CPBI vs VNRX Comparison
Compare CPBI & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- VNRX
- Stock Information
- Founded
- CPBI 2023
- VNRX N/A
- Country
- CPBI United States
- VNRX United States
- Employees
- CPBI N/A
- VNRX N/A
- Industry
- CPBI
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CPBI
- VNRX Health Care
- Exchange
- CPBI Nasdaq
- VNRX Nasdaq
- Market Cap
- CPBI 58.1M
- VNRX 52.4M
- IPO Year
- CPBI N/A
- VNRX N/A
- Fundamental
- Price
- CPBI $14.55
- VNRX $0.50
- Analyst Decision
- CPBI
- VNRX Strong Buy
- Analyst Count
- CPBI 0
- VNRX 4
- Target Price
- CPBI N/A
- VNRX $4.17
- AVG Volume (30 Days)
- CPBI 1.3K
- VNRX 263.7K
- Earning Date
- CPBI 01-01-0001
- VNRX 05-15-2025
- Dividend Yield
- CPBI N/A
- VNRX N/A
- EPS Growth
- CPBI 29.70
- VNRX N/A
- EPS
- CPBI 1.62
- VNRX N/A
- Revenue
- CPBI $18,546,000.00
- VNRX $1,308,361.00
- Revenue This Year
- CPBI N/A
- VNRX $563.72
- Revenue Next Year
- CPBI N/A
- VNRX $160.43
- P/E Ratio
- CPBI $9.00
- VNRX N/A
- Revenue Growth
- CPBI 13.73
- VNRX 64.16
- 52 Week Low
- CPBI $9.96
- VNRX $0.40
- 52 Week High
- CPBI $15.50
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- CPBI 43.62
- VNRX 52.42
- Support Level
- CPBI $14.53
- VNRX $0.40
- Resistance Level
- CPBI $14.80
- VNRX $0.54
- Average True Range (ATR)
- CPBI 0.10
- VNRX 0.05
- MACD
- CPBI -0.04
- VNRX 0.00
- Stochastic Oscillator
- CPBI 4.26
- VNRX 73.57
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.